Division of Industrial Food Research, National Food Institute, Technical University of Denmark, Søltofts Plads, Lyngby, DK-Denmark.
BMC Microbiol. 2011 Jun 22;11:144. doi: 10.1186/1471-2180-11-144.
Characterization and use of antimicrobial peptides (AMPs) requires that their mode of action is determined. The interaction of membrane-active peptides with their target is often established using model membranes, however, the actual permeabilization of live bacterial cells and subsequent killing is usually not tested. In this report, six α-peptide/β-peptoid chimeras were examined for the effect of amino acid/peptoid substitutions and chain length on the membrane perturbation and subsequent killing of food-borne and clinical bacterial isolates.
All six AMP analogues inhibited growth of twelve food-borne and clinical bacterial strains including Extended Spectrum Beta-Lactamase-producing Escherichia coli. In general, the Minimum Inhibitory Concentrations (MIC) against Gram-positive and -negative bacteria were similar, ranging from 1 to 5 μM. The type of cationic amino acid only had a minor effect on MIC values, whereas chain length had a profound influence on activity. All chimeras were less active against Serratia marcescens (MICs above 46 μM). The chimeras were bactericidal and induced leakage of ATP from Staphylococcus aureus and S. marcescens with similar time of onset and reduction in the number of viable cells. EDTA pre-treatment of S. marcescens and E. coli followed by treatment with chimeras resulted in pronounced killing indicating that disintegration of the Gram-negative outer membrane eliminated innate differences in susceptibility. Chimera chain length did not influence the degree of ATP leakage, but the amount of intracellular ATP remaining in the cell after treatment was influenced by chimera length with the longest analogue causing complete depletion of intracellular ATP. Hence some chimeras caused a complete disruption of the membrane, and this was parallel by the largest reduction in number of viable bacteria.
We found that chain length but not type of cationic amino acid influenced the antibacterial activity of a series of synthetic α-peptide/β-peptoid chimeras. The synthetic chimeras exert their killing effect by permeabilization of the bacterial cell envelope, and the outer membrane may act as a barrier in Gram-negative bacteria. The tolerance of S. marcescens to chimeras may be due to differences in the composition of the lipopolysaccharide layer also responsible for its resistance to polymyxin B.
抗菌肽(AMPs)的特性和应用需要确定其作用模式。通常使用模型膜来确定膜活性肽与靶标的相互作用,但是通常不测试活细菌细胞的实际通透性及其随后的杀伤。在本报告中,研究了六种α肽/β肽仿物,以研究氨基酸/肽仿物取代和链长对食源性病原体和临床分离菌的膜扰动和随后杀伤的影响。
所有六种 AMP 类似物均抑制了十二种食源性病原体和临床分离株的生长,包括产生扩展谱β-内酰胺酶的大肠杆菌。通常,革兰氏阳性和革兰氏阴性细菌的最小抑菌浓度(MIC)相似,范围为 1 至 5μM。阳离子氨基酸的类型对 MIC 值的影响很小,而链长对活性有深远的影响。所有嵌合体对粘质沙雷氏菌(MIC 值高于 46μM)的活性较低。嵌合体是杀菌的,并诱导金黄色葡萄球菌和粘质沙雷氏菌的 ATP 渗漏,其起始时间和存活细胞数量减少相似。用 EDTA 预处理粘质沙雷氏菌和大肠杆菌,然后用嵌合体处理,导致明显的杀伤,表明革兰氏阴性外膜的崩解消除了固有敏感性的差异。嵌合体链长不影响 ATP 渗漏的程度,但是在用嵌合体处理后细胞内 ATP 的剩余量受嵌合体长度的影响,最长的类似物导致细胞内 ATP 完全耗尽。因此,一些嵌合体完全破坏了膜,这与存活细菌数量的最大减少是平行的。
我们发现,链长而不是阳离子氨基酸的类型影响了一系列合成的α肽/β肽嵌合体的抗菌活性。合成嵌合体通过细菌细胞包膜的通透性发挥其杀菌作用,而外膜可能在革兰氏阴性菌中起屏障作用。粘质沙雷氏菌对嵌合体的耐受性可能是由于其脂多糖层的组成差异所致,该层也负责其对多粘菌素 B 的耐药性。